Unknown

Dataset Information

0

Association between MDM2-SNP309 and hepatocellular carcinoma in Taiwanese population.


ABSTRACT: AIM:To investigate the risk association and compare the onset age of hepatocellular carcinoma (HCC) patients in Taiwan with different genotypes of MDM2-SNP309. METHODS:We analyzed MDM2-SNP309 genotypes from 58 patients with HCC and 138 cancer-free healthy controls consecutively. Genotyping of MDM2-SNP309 was conducted by restriction fragment length polymorphism assay. RESULTS:The proportion of homozygous MDM2-SNP309 genotype (G/G) in cases and cancer-free healthy controls was similar (17.2% vs 16.7%). Multivariate analysis showed that the risk of G/G genotype of MDM2-SNP309 vs wild-type T/T genotype in patients with HCC was not significant (OR = 1.265, 95% CI = 0.074-21.77) after adjustment for sex, hepatitis B or C virus infection, age, and cardiovascular disease/diabetes. Nevertheless, there was a trend that GG genotype of MDM2-SNP309 might increase the risk in HCC patients infected with hepatitis virus (OR = 2.568, 95% CI = 0.054-121.69). Besides, the homozygous MDM2-SNP309 genotype did not exhibit a significantly earlier age of onset for HCC. CONCLUSION:Current data suggest that the association between MDM2-SNP309 GG genotype and HCC is not significant, while the risk may be enhanced in patients infected by hepatitis virus in Taiwan.

SUBMITTER: Leu JD 

PROVIDER: S-EPMC2785064 | biostudies-literature | 2009 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Association between MDM2-SNP309 and hepatocellular carcinoma in Taiwanese population.

Leu Jyh-Der JD   Lin I-Feng IF   Sun Ying-Fang YF   Chen Su-Mei SM   Liu Chih-Chao CC   Lee Yi-Jang YJ  

World journal of gastroenterology 20091101 44


<h4>Aim</h4>To investigate the risk association and compare the onset age of hepatocellular carcinoma (HCC) patients in Taiwan with different genotypes of MDM2-SNP309.<h4>Methods</h4>We analyzed MDM2-SNP309 genotypes from 58 patients with HCC and 138 cancer-free healthy controls consecutively. Genotyping of MDM2-SNP309 was conducted by restriction fragment length polymorphism assay.<h4>Results</h4>The proportion of homozygous MDM2-SNP309 genotype (G/G) in cases and cancer-free healthy controls w  ...[more]

Similar Datasets

| S-EPMC6392589 | biostudies-literature
| S-EPMC6745237 | biostudies-literature
| S-EPMC5530310 | biostudies-literature
| S-EPMC6310604 | biostudies-other
| S-EPMC7214377 | biostudies-literature
| S-EPMC3881546 | biostudies-literature
| S-EPMC4676618 | biostudies-literature
| S-EPMC3574032 | biostudies-literature
| S-EPMC3729233 | biostudies-literature
| S-EPMC4483806 | biostudies-literature